Israel Securities Authority Warns of Foreign Investment Sites Targeting Hebrew Speakers
Translated & summarized from TheMarker by baba
The Israel Securities Authority is warning investors about foreign websites offering investment services in Hebrew. These sites are not regulated in Israel, and investors may face significant difficulties recovering funds or resolving disputes due to foreign legal jurisdictions. The ISA stresses that a Hebrew interface does not imply Israeli regulation.
The story in 5 lines · by baba
- Foreign investment websites are targeting Israelis by operating in Hebrew, warns the Israel Securities Authority.
- These foreign sites offer trading, investment, and financial management services without Israeli oversight.
- A Hebrew-language website does not mean the operating entity is licensed or regulated in Israel.
- Investors may face severe difficulties recovering funds or resolving disputes due to foreign applicable law.
- The ISA advises investors to verify the regulatory status of any investment platform before engaging.
The Israel Securities Authority (ISA) has issued a warning regarding foreign investment websites that are targeting Israeli investors by operating in Hebrew. These sites, which offer trading, investment, or financial management services, often have no connection to Israel and are not supervised by Israeli authorities.
Investors searching for terms like "investments" or "trading platform" on search engines may encounter these foreign sites, which present themselves in Hebrew. The ISA emphasizes that a website being in Hebrew does not indicate that the operating entity is Israeli, licensed, or regulated in Israel.
The authority cautions that if investors face difficulties withdrawing funds or encounter disputes, they may discover that foreign law applies. This situation could make enforcing rights and recovering money significantly difficult, and sometimes impossible.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
